Bacterial RNase P as a potential target for novel anti-infectives

Current Opinion in Investigational Drugs

Volumn 4, Issue 8, 2003, Pages 937-943

  Eder, Paul S ^a   Hatfield, Cynthia ^b   Vioque, Agustin ^c   Gopalan, Venkat ^b  

^a Message Pharmaceuticals Inc   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Holoenzyme; Ribonucleoprotein (RNP) complex; Ribozyme; RNase P

Indexed keywords

AMICETIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AROTINOID; BACTERIAL ENZYME; BENZIMIDAZOLE DERIVATIVE; BLASTICIDIN S; CALCIPOTRIOL; DITHRANOL; ETRETIN; FRAMYCETIN; HEXAARGININE NEOMYCIN B; HOLOENZYME; ISOTRETINOIN; KANAMYCIN B; PAROMOMYCIN; PEPTIDYLTRANSFERASE INHIBITOR; PROTEIN SUBUNIT; PUROMYCIN; RETINOIC ACID; RETINOID DERIVATIVE; RIBONUCLEASE P; RIBONUCLEASE P INHIBITOR; UNCLASSIFIED DRUG;

BACTERIUM; BINDING AFFINITY; DRUG ACTIVITY; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; ESCHERICHIA COLI; HOST; IC 50; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; NONHUMAN; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; PROTEIN SUBUNITS; RIBONUCLEASE P; RNA, BACTERIAL; SUBSTRATE SPECIFICITY;

EID: 0141607973     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Walsh C: Molecular mechanisms that confer antibacterial drug resistance. Nature (2000) 406(6797):775-781.
2. Drysdale MJ, Lentzen G, Matassova N, Murchie A, Aboul-Ela F, Afshar M: RNA as a drug target. Prog Med Chem (2002) 39:73-119. A good description to support RNA as a valid molecular target.
3. Moir DT, Shaw KJ, Hare RS, Vovis GF: Genomics and antimicrobial drug discovery. Antimicrob Agents Chemother (1999) 43(3):439-446. Explanations of both the criteria that define a good anti-infective target and the use of genomics to identify new targets for development of novel antimicrobials.
4. Altman S, Kirsebom L: The RNA World. Gesteland RF, Cech T, Akins JF (Eds), CSH Laboratory Press, Cold Spring Harbor, NY, USA (1999): 351-380.
5. Frank DN, Pace NR: Ribonuclease P: Unity and diversity in a tRNA processing ribozyme. Annu Rev Biochem (1998) 67:153-180.
6. Hall TA, Brown JW: The ribonuclease P family. Methods Enzymol (2001) 341:56-77.
7. Jarrous N: Human ribonuclease P: Subunits, function, and intranuclear localization. RNA (2002) 8(1):1-7.
8. Xiao S, Scott F, Fierke CA, Engelke DR: Eukaryotic ribonuclease P: A plurality of ribonucleoprotein enzymes. Annu Rev Biochem (2002) 71:165-189.
9. Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S: The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell (1983) 35(3 Pt 2):849-857. Seminal work which demonstrated that the essential RNA subunit of bacterial RNase P is also the catalytic subunit of the holoenzyme.
10. Bothwell AL, Garber RL, Altman S: Nucleotide sequence and in vitro processing of a precursor molecule to Escherichia coli 4.5 S RNA. J Biol Chem (1976) 251(23):7709-7716.
11. Brown S, Fournier MJ: The 4.5 S RNA gene of Escherichia coli is essential for cell growth. J Mol Biol (1984) 178(3):533-550.
12. Komine Y, Kitabatake M, Yokogawa T, Nishikawa K, Inokuchi H: A tRNA-like structure is present in 10Sa RNA, a small stable RNA from Escherichia coli. Proc Natl Acad Sci USA (1994) 91(20):9223-9227.
13. Huang C, Wolfgang MC, Withey J, Koomey M, Friedman DI: Charged tmRNA but not tmRNA-mediated proteolysis is essential for Neisseria gonorrhoeae viability. EMBO J (2000) 19(15):1098-1107.
14. Biswas R, Ledman DW, Fox RO, Altman S, Gopalan V: Mapping RNA-protein interactions in ribonuclease P from Escherichia coli using disulfide-linked EDTA-Fe. J Mol Biol (2000) 296(1):19-31.
15. Rox C, Feltens R, Pfeiffer T, Hartmann RK: Potential contact sites between the protein and RNA subunit in the Bacillus subtilis RNase P holoenzyme. J Mol Biol (2002) 315(4):551-560.
16. Christian EL, Zahler NH, Kayne NM, Harris ME: Analysis of substrate recognition by the ribonucleoprotein endonuclease RNase P. Methods (2002) 28(3):307-322. An outstanding review of various methods used to dissect the molecular interactions of the bacterial RNase P holoenzyme with its ptRNA substrate.
17. Jovanovic M, Sanchez R, Altman S, Gopalan V: Elucidation of structure-function relationships in the protein subunit of bacterial RNase P using a genetic complementation approach. Nucleic Acids Res (2002) 30(23):5065-5073.
18. Tsai H-Y, Masquida B, Biswas R, Westhof E, Gopalan V: Molecular modeling of the three-dimensional structure of the bacterial RNase P holoenzyme. J Mol Biol (2003) 325(4):661-675. Use of footprinting and crosslinking data to generate a tertiary structure model of the RNA and protein subunits complexed with a ptRNA substrate.
19. Vioque A, Arnez J, Altman S: Protein-RNA interactions in the RNase P holoenzyme from Escherichia coli. J Mol Biol (1988) 202(4):835-848. Description of methods for overexpression, purification and reconstitution of both subunits of bacterial RNase P.
20. Rivera-Leon R, Green CJ, Vold BS: High-level expression of soluble recombinant RNase P protein from Escherichia coli. J Bacteriol (1995) 177(9):2564-2566.
21. Guerrier-Takada C, Li Y, Altman S: Artificial regulation of gene expression in Escherichia coli by RNase P. Proc Natl Acad Sci USA (1995) 92(24):11115-11119.
22. Dong H, Kirsebom LA, Nilsson L: Growth rate regulation of 4.5 S RNA and M1 RNA the catalytic subunit of Escherichia coli RNase P. J Mol Biol (1996) 261(3):303-308.
23. Bremer H, Dennis PP: Modulation of chemical composition and other parameters of the cell by growth rate. In: Escherichia coli and Salmonella Typhimurium: Cellular and Molecular Biology. Neidhardt FC, Ingraham JL, Magasanik B, Low KB, Schaechter M (Eds), American Society of Microbiology, Washington, DC, USA (1987):1527-1542.
24. Schedl P, Primakoff P: Mutants of Escherichia coli thermosensitive for the synthesis of transfer RNA. Proc Natl Acad Sci USA (1973) 70(7):2091-2095.
25. Pace NR, Brown JW: Evolutionary perspective on the structure and function of ribonuclease P, a ribozyme. J Bacteriol (1995) 177(8):1919-1928.
26. Chen JL, Nolan JM, Harris ME, Pace NR: Comparative photocrosslinking analysis of the tertiary structures of Escherichia coli and Bacillus subtilis RNase P RNAs. EMBO J (1998) 17(5):1515-1525. Combined use of phylogenetic comparative sequence analysis and biochemical data to build a tertiary structure model of the catalytic RNA subunit of bacterial RNase P.
27. Massire C, Jaeger L, Westhof E: Derivation of the three-dimensional architecture of bacterial ribonuclease P RNAs from comparative sequence analysis. J Mol Biol (1998) 279(4):773-793. Combined use of phylogenetic comparative sequence analysis and biochemical data to build a tertiary structure model of the catalytic RNA subunit of bacterial RNase P.
28. Guerrier-Takada C, Altman S: Reconstitution of enzymatic activity from fragments of M1 RNA. Proc Natl Acad Sci USA (1992) 89(4):1266-1270.
29. Pan T: Higher order folding and domain analysis of the ribozyme from Bacillus subtilis ribonuclease P. Biochemistry (1995) 34(3):902-909.
30. Kirsebom LA, Svärd SG: Base pairing between Escherichia coli RNase P RNA and its substrate. EMBO J (1994) 13(20):4870-4876. This study and reference [31] provide experimental evidence for interaction of the C domain in RNase P RNA with the highly conserved 3′ CCA sequence in the pTRNA substrate.
31. Oh BK, Pace NR: Interaction of the 3′-end of tRNA with ribonuclease P RNA. Nucleic Acids Res (1994) 22(20):4087-4094. This study and reference [30] provide experimental evidence for interaction of the C domain in RNase P RNA with the highly conserved 3′ CCA sequence in the pTRNA substrate.
32. Svärd SG, Kagardt U, Kirsebom LA: Phylogenetic comparative mutational analysis of the base-pairing between RNase P RNA and its substrate. RNA (1996) 2(5):463-472.
33. Stams T, Niranjanakumari S, Fierke CA, Christianson DW: Ribonuclease P protein structure: Evolutionary origins in the translational apparatus. Science (1998) 280(5364):752-755. The first high-resolution tertiary structure of the protein subunit of bacterial RNase P providing insights into its possible RNA-binding mechanisms.
34. Spitzfaden C, Nicholson N, Jones JJ, Guth S, Lehr R, Prescott CD, Hegg LA, Eggleston DS: The structure of ribonuclease P protein from Staphylococcus aureus reveals a unique binding site for single-stranded RNA. J Mol Biol (2000) 295(1):105-115.
35. Asp. Biochemistry (1998) 37(8):2393-2400. Detailed kinetic data (together with reference [36]) that helped establish the mechanistic role of the protein subunit in enhancing affinity for the substrate by promoting interactions with the leader sequence.
36. Asp. Biochemistry (1998) 37(26):9409-9416. Detailed kinetic data (together with reference [35]) that helped establish the mechanistic role of the protein subunit in enhancing affinity for the substrate by promoting interactions with the leader sequence.
37. Niranjanakumari S, Stams T, Crary SM, Christianson DW, Fierke CA: Protein component of the ribozyme ribonuclease P alters substrate recognition by directly contacting precursor tRNA. Proc Natl Acad Sci USA (1998) 95(26):15212-15217. Use of photochemical crosslinking to identify specific regions in the protein subunit of B subtilis RNase P that bind the ptRNA leader sequence upstream of the cleavage site.
38. Reich C, Olsen GJ, Pace B, Pace NR: Role of the protein moiety of ribonuclease P, a ribonucleoprotein enzyme. Science (1988) 239(4836):178-181.
39. Tallsjo A, Kirsebom LA: Product release is a rate-limiting step during cleavage by the catalytic RNA subunit of Escherichia coli RNase P. Nucleic Acids Res (1993) 21(1):51-57.
40. Kurz JC, Fierke CA: The affinity of magnesium binding sites in the Bacillus subtilis RNase P × pre-tRNA complex is enhanced by the protein subunit. Biochemistry (2002) 41(30):9545-9558.
41. Pascual A, Vioque A: Cloning, purification and characterization of the protein subunit of ribonuclease P from the cyanobacterium Synechocystis sp. PCC 6803. Eur J Biochem (1996) 24(1):17-24.
42. Wang S, Huber PW, Cui M, Czarnik AW, Mei HY: Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry (1998) 37(16):5549-5557.
43. Gopalan V, Baxevanis AD, Landsman D, Altman S: Analysis of the functional role of conserved residues in the protein subunit of ribonuclease P from Escherichia coli. J Mol Biol (1997) 267(4):818-829.
44. Kaye NM, Zahler NH, Christian EL, Harris ME: Conservation of helical structure contributes to functional metal ion interactions in the catalytic domain of ribonuclease P RNA. J Mol Biol (2002) 324(3):429-442.
45. Vioque A: Protein synthesis inhibitors and catalytic RNA. Effect of puromycin on tRNA precursor processing by the RNA component of Escherichia coli RNase P. FEBS Lett (1989) 246(1-2):137-139.
46. Potuschak T, Rossmanith W, Karwan R: RNase MRP and RNase P share a common substrate. Nucleic Acids Res (1993) 21(14):3239-3243.
47. True HL, Celander DW: Ribonuclease P of Tetrahymena thermophila. J Biol Chem (1996) 271(28):16559-16566.
48. Rossmanith W, Karwan RM: Characterization of human mitochondrial RNase P: Novel aspects in tRNA processing. Biochem Biophys Res Commun (1998) 247(2):234-241.
49. 2+ ions required for RNase P catalysis.
50. Hoch I, Berens C, Westhof E, Schroeder R: Antibiotic inhibition of RNA catalysis: Neomycin B binds to the catalytic core of the td group I intron displacing essential metal ions. J Mol Biol (1998) 282(3):557-569.
51. Rogers J, Chang AH, Von Ahsen U, Schroeder R, Davies J: Inhibition of the self-cleavage reaction of the human hepatitis δ virus ribozyme by antibiotics. J Mol Biol (1996) 259(5):916-925.
52. Walter F, Vicens Q, Westhof E: Aminoglycoside-RNA interactions. Curr Opin Chem Biol (1999) 3(6):694-704. An excellent review of the interaction of various aminoglycoside antibiotics with RNA.
53. Cabrera C, Gutierrez A, Barretina J, Blanco J, Litovchick A, Lapidot A, Clotet B, Este JA: Anti-HIV activity of a novel aminoglycoside-arginine conjugate. Antiviral Res (2002) 53(1):1-8.
54. Eubank TD, Biswas R, Jovanovic M, Litovchick A, Lapidot A, Gopalan V: Inhibition of bacterial RNase P by aminoglycoside-arginine conjugates. FEBS Lett (2002) 511(1-3):107-112.
55. Stathopoulos C, Tsagla A, Tekos A, Drainas D: Effect of peptidyltransferase inhibitors on ribonuclease P activity from Dictyostelium discoideum. Effect of antibiotics on RNase P. Mol Biol Rep (2000) 27(2):107-111.
56. Tekos A, Tsagla A, Stathopoulos C, Drainas D: Inhibition of eukaryotic ribonuclease P activity by aminoglycosides: Kinetic studies. FEBS Lett (2000) 485(1):71-75.
57. Papadimou E, Georgiou S, Tsambaos D, Drainas D: Inhibition of rinonuclease P activity by retinoids. J Biol Chem (1998) 273(38):24375-24378.
58. Papadimou E, Monastirli A, Tsambaos D, Merk HF, Drainas D: Inhibitory effects of arotinoids on tRNA biogenesis. Skin Pharmacol Appl Skin Physiol (2000) 13(6):345-351.
59. Drainas D, Papadimou E, Monastirli A, Tsambaos D, Merk HF: Dose-dependent inhibition of ribonuclease P activity by anthralin. Skin Pharmacol Appl Skin Physiol (2000) 13(2):128-132.
60. Papadimou E, Monastirli A, Stathopoulos C, Tsambaos D, Drainas D: Modulation of ribonuclease P activity by calcipotriol. Eur J Biochem (2000) 267(4):1173-1177.
61. Hori Y, Bichenkova EV, Wilton AN, El-Attug MN, Sadat-Ebrahimi S, Tanaka T, Kikuchi Y, Araki M, Sugiura Y, Douglas KT: Synthetic inhibitors of the processing of pretransfer RNA by ribonuclease P ribozyme: Enzyme inhibitors which act by binding to substrate. Biochemistry (2001) 40(3):603-608.
62. Svärd SG, Kirsebom LA: Determinants of Escherichia coli RNase P cleavage site selection: A detailed in vitro and in vivo analysis. Nucleic Acids Res (1993) 21(3):427-434.
63. Gaur RK, Krupp G: Modification interference approach to detect ribose moieties important for the optimal activity of a ribozyme. Nucleic Acids Res (1993) 21(1):21-26.
64. Loria A, Niranjanakumari S, Fierke CA, Pan T: Recognition of a pre-tRNA substrate by the Bacillus subtilis RNase P holoenzyme. Biochemistry (1998) 37(44):15466-15473.
65. Xavier KA, Eder PS, Giordano T: RNA as drug target: Methods for biophysical characterization and screening. Trends Biotechnol (2000) 18(8):349-356.
66. Hamasaki K, Rando RR: A high-throughput fluorescence screen to monitor specific binding of antagonists to RNA targets. Anal Biochem (1998) 261(2):183-190.
67. Abo T, Ueda K, Sunohara T, Ogawa K, Aiba H: SsrA-mediated protein tagging in the presence of miscoding drugs and its physiological role in Escherichia coli. Genes Cells (2002) 7(7):629-638.
68. De La Cruz J, Vioque A: Increased sensitivity to protein synthesis inhibitors in cells lacking tmRNA. RNA (2001) 7(12):1708-1716.
69. Vioque A, De La Cruz J: Trans-translation and protein synthesis inhibitors. FEMS Microbiol Lett (2003) 218(1):9-14.
70. Koradi R, Billeter M, Wuthrich K: MOLMOL: A program for display and analysis of macromolecular structures. J Mol Graph (1996) 14(1):51-55.